4-O-benzyl 3-O-(9H-fluoren-9-ylmethyl) (4S)-2,2-dioxooxathiazinane-3,4-dicarboxylate;methyl (2S)-2-amino-3-(1H-indol-3-yl)propanoate;methyl (2S)-3-(1H-indol-3-yl)-2-[(3S)-3-methyl-2-oxopyrrolidin-1-yl]propanoate
C55H57N5O12S — CID 158840891
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-O-benzyl 3-O-(9H-fluoren-9-ylmethyl) (4S)-2,2-dioxooxathiazinane-3,4-dicarboxylate;methyl (2S)-2-amino-3-(1H-indol-3-yl)propanoate;methyl (2S)-3-(1H-indol-3-yl)-2-[(3S)-3-methyl-2-oxopyrrolidin-1-yl]propanoate
4-O-benzyl 3-O-(9H-fluoren-9-ylmethyl) (4S)-2,2-dioxooxathiazinane-3,4-dicarboxylate;methyl (2S)-2-amino-3-(1H-indol-3-yl)propanoate;methyl (2S)-3-(1H-indol-3-yl)-2-[(3S)-3-methyl-2-oxopyrrolidin-1-yl]propanoate (PubChem CID 158840891) has the molecular formula C55H57N5O12S and a molecular weight of 1012.15 g/mol. Its IUPAC name is 4-O-benzyl 3-O-(9H-fluoren-9-ylmethyl) (4S)-2,2-dioxooxathiazinane-3,4-dicarboxylate;methyl (2S)-2-amino-3-(1H-indol-3-yl)propanoate;methyl (2S)-3-(1H-indol-3-yl)-2-[(3S)-3-methyl-2-oxopyrrolidin-1-yl]propanoate.
Molecular Properties
| Compound Name | 4-O-benzyl 3-O-(9H-fluoren-9-ylmethyl) (4S)-2,2-dioxooxathiazinane-3,4-dicarboxylate;methyl (2S)-2-amino-3-(1H-indol-3-yl)propanoate;methyl (2S)-3-(1H-indol-3-yl)-2-[(3S)-3-methyl-2-oxopyrrolidin-1-yl]propanoate |
|---|---|
| PubChem CID | 158840891 |
| Molecular Formula | C55H57N5O12S |
| Molecular Weight | 1012.15 g/mol |
| Exact Mass | 1011.37 |
| IUPAC Name | 4-O-benzyl 3-O-(9H-fluoren-9-ylmethyl) (4S)-2,2-dioxooxathiazinane-3,4-dicarboxylate;methyl (2S)-2-amino-3-(1H-indol-3-yl)propanoate;methyl (2S)-3-(1H-indol-3-yl)-2-[(3S)-3-methyl-2-oxopyrrolidin-1-yl]propanoate |
| SMILES | COC(=O)[C@@H](N)Cc1c[nH]c2ccccc12.COC(=O)[C@H](Cc1c[nH]c2ccccc12)N1CC[C@H](C)C1=O.O=C(OCc1ccccc1)[C@@H]1CCOS(=O)(=O)N1C(=O)OCC1c2ccccc2-c2ccccc21 |
| InChI | InChI=1S/C26H23NO7S.C17H20N2O3.C12H14N2O2/c28-25(32-16-18-8-2-1-3-9-18)24-14-15-34-35(30,31)27(24)26(29)33-17-23-21-12-6-4-10-19(21)20-11-5-7-13-22(20)23;1-11-7-8-19(16(11)20)15(17(21)22-2)9-12-10-18-14-6-4-3-5-13(12)14;1-16-12(15)10(13)6-8-7-14-11-5-3-2-4-9(8)11/h1-13,23-24H,14-17H2;3-6,10-11,15,18H,7-9H2,1-2H3;2-5,7,10,14H,6,13H2,1H3/t24-;11-,15-;10-/m000/s1 |
| InChIKey | IYFOHKDHSKFGGT-RYLMXUSOSA-N |
| XLogP | 7.35 |
| TPSA | 229.72 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 73 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1012.15 |
| LogP ≤ 5 | 7.35 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 13 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158840891 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.